Clinical Use of Propranolol Reduces Biomarkers of Proliferation in Gastric Cancer.

Front Oncol · 2021 · PMC8108985 · PMID 33981600

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Furthermore, the expression of IFN-γ, GrzmB, T-bet on CD8 + T cell were numerically lower in the propranolol treated patients, although this did not reach statistical significance ( Figures 5D–G ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.